×

Active Pharmaceutical Ingredients (API) Market Report


Company Analysis, History and Future Overview, Global Sales Trends by 2025


Published Date: 2019-08-30   |   Pages: 135   |   Tables: 164   |  Report ID: 7588 |  Industry: Chemical & Material  |   Format : pdf word ppt excel



   Request Sample     Request Customization    Request Methodology
  • SELECT LICENSE TYPE :

  •   Single License
  •  Multi User License
  •  Corporate License


The global Active Pharmaceutical Ingredients (API) market is extensively researched about in the report with major focus on the vendor landscape, changes in competition, future growth opportunities, regional expansion, and other important aspects. The report comes out as a powerful tool to gain access to useful insights into the global Active Pharmaceutical Ingredients (API) market and important recommendations to help increase sales and profit margins. It also presents itself as a compilation of intelligent research studies that dig deep into various critical facets of the global Active Pharmaceutical Ingredients (API) market. Market players can safely add the report to their repository of most important resources of accurate information and data related to the global Active Pharmaceutical Ingredients (API) market.

The analysts who have prepared the report are market research experts and possess vast knowledge about the global Active Pharmaceutical Ingredients (API) market. Readers can easily rely on the authentic and unbiased analysis of the global Active Pharmaceutical Ingredients (API) market provided in the report. Some of the vital factors that the report focuses on are CAGR, market size in terms of revenue and production, sales growth, consumer behavior, industry value chain, and market share.

Market Dynamics

The report provides comprehensive assessment of crucial dynamics including growth factors, restraints, challenges, trends, opportunities, and business prospects of the global Active Pharmaceutical Ingredients (API) market. The analysts used primary and secondary research techniques to prepare a broad account of significant market dynamics. The report not only offers a vast study on market dynamics related to current situations but also future scenarios of the global Active Pharmaceutical Ingredients (API) market. It could help players in their efforts to stay ahead of the competition and also prepare well to effectively deal with future challenges in the global Active Pharmaceutical Ingredients (API) market. Importantly, the report also includes an extensive study of market dynamics specific to different market segments and regions.

Market Segments
By Product

●  Synthetic APIs
●   Biotech APIs

By Application

●  CNS
●   Cardiovascular
●   Genitourinary/Hormonal Drugs
●   Respiratory
●   Rheumatology
●   Diabetes
●   Oncology
●   Others

The analysts authoring the report have segmented the global Active Pharmaceutical Ingredients (API) market by type of product and application. In order to form accurate estimations of the revenue growth of different segmental and sub-segmental markets, the researchers used data triangulation and market breakdown procedures. Readers are provided with thorough analysis of the market potential and growth outlook of all segments studied in the report. Players can use the exhaustive segmental analysis provided in the report to identify key growth pockets of the global Active Pharmaceutical Ingredients (API) market. The analysts studied a number of factors from the supply as well as demand side of the global Active Pharmaceutical Ingredients (API) market to prepare a detailed segmental analysis.

By Region

world_regions

The authors of the report have done a brilliant job of pin-pointing specific growth opportunities in each region and country important for the global Active Pharmaceutical Ingredients (API) market. The geographical analysis included in the report offers an in-depth study of growth drivers, trends, and other dynamics of key regional markets. Players can use the information and data provided in the geographical analysis to create result-oriented business expansion plans and strategies specific to each regional market. All of the regional markets analyzed in the report are deeply assessed on the basis of production, consumption, market share, value, volume, growth rate, and other vital factors.

Research Methodology

The key purpose of the detailed study is to gain insights into the overall performance of the market. This report will assist readers in understanding the quantitative and qualitative aspects of the market. The study begins with an executive summary that consists of brief information about key statistic and findings of the market. Key trends, success factors, segmental and regional analysis, opportunity assessment, and analysis of market structure are some of the important elements covered in this newly published report. This report ends with a dashboard view of the competitive landscape that includes the profiles of various top players operating in the market. The sole purpose behind this is to provide the present status of the competitions in the market.

Key Players

Some of the key players operating in the global Active Pharmaceutical Ingredients (API) market are
●   Teva  
● Mylan  
● DSM  
● Aurobindo Pharma  
● Aspen  
● Novartis  
● BASF  
● Pfizer  
● Huahai Pharmaceutical  
● Hisun Pharmaceutical  
● Sun Pharmaceutical Industries  
● Zhejiang Medicine  
● Dr. Reddy’s Laboratories  
● Zhejiang NHU  
● Bayer  
● NCPC  
● AbbVie  
● Shandong Xinhua Pharmaceutical  
● Northeast Pharm  
● Harbin Pharmaceutical  
● LKPC

The chemicals and materials sector has been witnessing an exponential rise in the past few years. The industrial boom and infrastructural growth across the globe has had a positive impact on the chemical and materials industry. Chemicals are an integral part of many industries, which, over the years, have created lucrative opportunities for players. Similarly, materials are an indispensable part of myriad industries. The rise of the chemicals and materials sector has been mapped by QYR Consulting through exhaustive research reports.

Analysts have used investigative approach to deduce important elements pertinent to the industry. The reports are aimed towards giving the reader a holistic approach about the industry’s development and future scenario. Competitive landscapes have been written with in-depth analysis of the historical data and careful understanding of the management styles. QYR Consulting aims to provide the readers a guided approach towards making well-informed business decisions through its research reports.

Table of Contents  
 
1 Report Overview  
    1.1 Research Scope 
    1.2 Major Manufacturers Covered in This Report 
    1.3 Market Segment by Type 
        1.3.1 Global Active Pharmaceutical Ingredients (API) Market Size Growth Rate by Type 
        1.3.2 Synthetic APIs 
        1.3.3 Biotech APIs 
    1.4 Market Segment by Application 
        1.4.1 Global Active Pharmaceutical Ingredients (API) Market Share by Application (2019-2025) 
        1.4.2 CNS 
        1.4.3 Cardiovascular 
        1.4.4 Genitourinary/Hormonal Drugs 
        1.4.5 Respiratory 
        1.4.6 Rheumatology 
        1.4.7 Diabetes 
        1.4.8 Oncology 
        1.4.9 Others 
    1.5 Study Objectives 
    1.6 Years Considered 
 
2 Global Growth Trends  
    2.1 Production and Capacity Analysis 
        2.1.1 Global Active Pharmaceutical Ingredients (API) Production Value 2014-2025 
        2.1.2 Global Active Pharmaceutical Ingredients (API) Production 2014-2025 
        2.1.3 Global Active Pharmaceutical Ingredients (API) Capacity 2014-2025 
        2.1.4 Global Active Pharmaceutical Ingredients (API) Marketing Pricing and Trends 
    2.2 Key Producers Growth Rate (CAGR) 2019-2025 
        2.2.1 Global Active Pharmaceutical Ingredients (API) Market Size CAGR of Key Regions 
        2.2.2 Global Active Pharmaceutical Ingredients (API) Market Share of Key Regions 
2.3 Industry Trends 
        2.3.1 Market Top Trends 
        2.3.2 Market Drivers 
 
3 Market Share by Manufacturers  
    3.1 Capacity and Production by Manufacturers 
        3.1.1 Global Active Pharmaceutical Ingredients (API) Capacity by Manufacturers 
        3.1.2 Global Active Pharmaceutical Ingredients (API) Production by Manufacturers 
    3.2 Revenue by Manufacturers 
        3.2.1 Active Pharmaceutical Ingredients (API) Revenue by Manufacturers (2014-2019) 
        3.2.2 Active Pharmaceutical Ingredients (API) Revenue Share by Manufacturers (2014-2019) 
        3.2.3 Global Active Pharmaceutical Ingredients (API) Market Concentration Ratio (CR5 and HHI) 
    3.3 Active Pharmaceutical Ingredients (API) Price by Manufacturers 
    3.4 Key Manufacturers Active Pharmaceutical Ingredients (API) Plants/Factories Distribution and Area Served 
    3.5 Date of Key Manufacturers Enter into Active Pharmaceutical Ingredients (API) Market 
    3.6 Key Manufacturers Active Pharmaceutical Ingredients (API) Product Offered 
    3.7 Mergers & Acquisitions, Expansion Plans 
 
4 Market Size by Type  
    4.1 Production and Production Value for Each Type 
        4.1.1 Synthetic APIs Production and Production Value (2014-2019) 
        4.1.2 Biotech APIs Production and Production Value (2014-2019) 
    4.2 Global Active Pharmaceutical Ingredients (API) Production Market Share by Type 
    4.3 Global Active Pharmaceutical Ingredients (API) Production Value Market Share by Type 
    4.4 Active Pharmaceutical Ingredients (API) Ex-factory Price by Type 
 
5 Market Size by Application  
    5.1 Overview 
    5.2 Global Active Pharmaceutical Ingredients (API) Consumption by Application 
 
6 Production by Regions  
    6.1 Global Active Pharmaceutical Ingredients (API) Production (History Data) by Regions 2014-2019 
    6.2 Global Active Pharmaceutical Ingredients (API) Production Value (History Data) by Regions 
    6.3 North America 
        6.3.1 North AmericaActive Pharmaceutical Ingredients (API) Production Growth Rate 2014-2019 
        6.3.2 North America Active Pharmaceutical Ingredients (API) Production Value Growth Rate 2014-2019 
        6.3.3 Key Players in North America 
        6.3.4 North America Active Pharmaceutical Ingredients (API) Import & Export 
    6.4 Europe 
        6.4.1 Europe Active Pharmaceutical Ingredients (API) Production Growth Rate 2014-2019 
        6.4.2 Europe Active Pharmaceutical Ingredients (API) Production Value Growth Rate 2014-2019 
        6.4.3 Key Players in Europe 
        6.4.4 Europe Active Pharmaceutical Ingredients (API) Import & Export 
    6.5 China 
        6.5.1 China Active Pharmaceutical Ingredients (API) Production Growth Rate 2014-2019 
        6.5.2 China Active Pharmaceutical Ingredients (API) Production Value Growth Rate 2014-2019 
        6.5.3 Key Players in China 
        6.5.4 China Active Pharmaceutical Ingredients (API) Import & Export 
    6.6 Japan 
        6.6.1 Japan Active Pharmaceutical Ingredients (API) Production Growth Rate 2014-2019 
        6.6.2 Japan Active Pharmaceutical Ingredients (API) Production Value Growth Rate 2014-2019 
        6.6.3 Key Players in Japan 
        6.6.4 Japan Active Pharmaceutical Ingredients (API) Import & Export 
 
7 Active Pharmaceutical Ingredients (API) Consumption by Regions 
    7.1 Global Active Pharmaceutical Ingredients (API) Consumption (History Data) by Regions 
    7.2 North America 
        7.2.1 North America Active Pharmaceutical Ingredients (API) Consumption by Type 
        7.2.2 North America Active Pharmaceutical Ingredients (API) Consumption by Application 
        7.2.3 North America Active Pharmaceutical Ingredients (API) Consumption by Countries 
        7.2.4 U.S. 
        7.2.5 Canada 
        7.2.6 Mexico 
    7.3 Europe 
        7.3.1 Europe Active Pharmaceutical Ingredients (API) Consumption by Type 
        7.3.2 Europe Active Pharmaceutical Ingredients (API) Consumption by Application 
        7.3.3 Europe Active Pharmaceutical Ingredients (API) Consumption by Countries 
        7.3.4 Germany 
        7.3.5 France 
        7.3.6 UK 
        7.3.7 Italy 
        7.3.8 Russia 
    7.4 Asia Pacific 
        7.4.1 Asia Pacific Active Pharmaceutical Ingredients (API) Consumption by Type 
        7.4.2 Asia Pacific Active Pharmaceutical Ingredients (API) Consumption by Application 
        7.4.3 Asia Pacific Active Pharmaceutical Ingredients (API) Consumption by Regions 
        7.4.4 China 
        7.4.5 Japan 
        7.4.6 South Korea 
        7.4.7 India 
        7.4.8 Australia 
        7.4.9 Indonesia 
        7.4.10 Thailand 
        7.4.11 Malaysia 
        7.4.12 Philippines 
        7.4.13 Vietnam 
    7.5 Central & South America 
        7.5.1 Central & South America Active Pharmaceutical Ingredients (API) Consumption by Type 
        7.5.2 Central & South America Active Pharmaceutical Ingredients (API) Consumption by Application 
        7.5.3 Central & South America Active Pharmaceutical Ingredients (API) Consumption by Countries 
        7.5.4 Brazil 
    7.6 Middle East and Africa 
        7.6.1 Middle East and Africa Active Pharmaceutical Ingredients (API) Consumption by Type 
        7.6.2 Middle East and Africa Active Pharmaceutical Ingredients (API) Consumption by Application 
        7.6.3 Central & South America Active Pharmaceutical Ingredients (API) Consumption by Countries 
        7.6.4 Turkey 
        7.6.5 GCC Countries 
        7.6.6 Egypt 
        7.6.7 South Africa 
 
8 Company Profiles  
    8.1 Teva 
        8.1.1 Teva Company Details 
        8.1.2 Company Description and Business Overview 
        8.1.3 Production and Revenue of Active Pharmaceutical Ingredients (API) 
        8.1.4 Active Pharmaceutical Ingredients (API) Product Introduction 
        8.1.5 Teva Recent Development 
    8.2 Mylan 
        8.2.1 Mylan Company Details 
        8.2.2 Company Description and Business Overview 
        8.2.3 Production and Revenue of Active Pharmaceutical Ingredients (API) 
        8.2.4 Active Pharmaceutical Ingredients (API) Product Introduction 
        8.2.5 Mylan Recent Development 
    8.3 DSM 
        8.3.1 DSM Company Details 
        8.3.2 Company Description and Business Overview 
        8.3.3 Production and Revenue of Active Pharmaceutical Ingredients (API) 
        8.3.4 Active Pharmaceutical Ingredients (API) Product Introduction 
        8.3.5 DSM Recent Development 
    8.4 Aurobindo Pharma 
        8.4.1 Aurobindo Pharma Company Details 
        8.4.2 Company Description and Business Overview 
        8.4.3 Production and Revenue of Active Pharmaceutical Ingredients (API) 
        8.4.4 Active Pharmaceutical Ingredients (API) Product Introduction 
        8.4.5 Aurobindo Pharma Recent Development 
    8.5 Aspen 
        8.5.1 Aspen Company Details 
        8.5.2 Company Description and Business Overview 
        8.5.3 Production and Revenue of Active Pharmaceutical Ingredients (API) 
        8.5.4 Active Pharmaceutical Ingredients (API) Product Introduction 
        8.5.5 Aspen Recent Development 
    8.6 Novartis 
        8.6.1 Novartis Company Details 
        8.6.2 Company Description and Business Overview 
        8.6.3 Production and Revenue of Active Pharmaceutical Ingredients (API) 
        8.6.4 Active Pharmaceutical Ingredients (API) Product Introduction 
        8.6.5 Novartis Recent Development 
    8.7 BASF 
        8.7.1 BASF Company Details 
        8.7.2 Company Description and Business Overview 
        8.7.3 Production and Revenue of Active Pharmaceutical Ingredients (API) 
        8.7.4 Active Pharmaceutical Ingredients (API) Product Introduction 
        8.7.5 BASF Recent Development 
    8.8 Pfizer 
        8.8.1 Pfizer Company Details 
        8.8.2 Company Description and Business Overview 
        8.8.3 Production and Revenue of Active Pharmaceutical Ingredients (API) 
        8.8.4 Active Pharmaceutical Ingredients (API) Product Introduction 
        8.8.5 Pfizer Recent Development 
    8.9 Huahai Pharmaceutical 
        8.9.1 Huahai Pharmaceutical Company Details 
        8.9.2 Company Description and Business Overview 
        8.9.3 Production and Revenue of Active Pharmaceutical Ingredients (API) 
        8.9.4 Active Pharmaceutical Ingredients (API) Product Introduction 
        8.9.5 Huahai Pharmaceutical Recent Development 
    8.10 Hisun Pharmaceutical 
        8.10.1 Hisun Pharmaceutical Company Details 
        8.10.2 Company Description and Business Overview 
        8.10.3 Production and Revenue of Active Pharmaceutical Ingredients (API) 
        8.10.4 Active Pharmaceutical Ingredients (API) Product Introduction 
        8.10.5 Hisun Pharmaceutical Recent Development 
    8.11 Sun Pharmaceutical Industries 
    8.12 Zhejiang Medicine 
    8.13 Dr. Reddy’s Laboratories 
    8.14 Zhejiang NHU 
    8.15 Bayer 
    8.16 NCPC 
    8.17 AbbVie 
    8.18 Shandong Xinhua Pharmaceutical 
    8.19 Northeast Pharm 
    8.20 Harbin Pharmaceutical 
    8.21 LKPC 
 
9 Market Forecast: Production Side  
    9.1 Production and Production Value Forecast 
        9.1.1 Global Active Pharmaceutical Ingredients (API) Capacity, Production Forecast 2019-2025 
        9.1.2 Global Active Pharmaceutical Ingredients (API) Production Value Forecast 2019-2025 
    9.2 Active Pharmaceutical Ingredients (API) Production and Production Value Forecast by Regions 
        9.2.1 Global Active Pharmaceutical Ingredients (API) Production Value Forecast by Regions 
        9.2.2 Global Active Pharmaceutical Ingredients (API) Production Forecast by Regions 
    9.3 Active Pharmaceutical Ingredients (API) Key Producers Forecast 
        9.3.1 North America 
        9.3.2 Europe 
        9.3.3 China 
        9.3.4 Japan 
    9.4 Forecast by Type 
        9.4.1 Global Active Pharmaceutical Ingredients (API) Production Forecast by Type 
        9.4.2 Global Active Pharmaceutical Ingredients (API) Production Value Forecast by Type 
 
10 Market Forecast: Consumption Side  
    10.1 Consumption Forecast by Application 
    10.2 Active Pharmaceutical Ingredients (API) Consumption Forecast by Regions 
    10.3 North America Market Consumption Forecast 
        10.3.1 North America Active Pharmaceutical Ingredients (API) Consumption Forecast by Countries 2019-2025 
        10.3.2 U.S. 
        10.3.3 Canada 
        10.3.4 Mexico 
    10.4 Europe Market Consumption Forecast 
        10.4.1 Europe Active Pharmaceutical Ingredients (API) Consumption Forecast by Countries 2019-2025 
        10.4.2 France 
        10.4.3 UK 
        10.4.4 Italy 
        10.4.5 Russia 
    10.5 Asia Pacific Market Consumption Forecast 
        10.5.1 Asia Pacific Active Pharmaceutical Ingredients (API) Consumption Forecast by Regions 2019-2025 
        10.5.2 Japan 
        10.5.3 South Korea 
        10.5.4 India 
        10.5.5 Australia 
        10.5.6 Indonesia 
        10.5.7 Thailand 
        10.5.8 Malaysia 
        10.5.9 Philippines 
        10.5.10 Vietnam 
    10.6 Central & South America Market Consumption Forecast 
        10.6.1 Central & South America Active Pharmaceutical Ingredients (API) Consumption Forecast by Country 2019-2025 
    10.7 Middle East and Africa Market Consumption Forecast 
        10.7.1 Middle East and Africa Active Pharmaceutical Ingredients (API) Consumption Forecast by Countries 2019-2025 
        10.7.2 GCC Countries 
        10.7.3 Egypt 
        10.7.4 South Africa 
 
11 Value Chain and Sales Channels Analysis  
    11.1 Value Chain Analysis 
    11.2 Sales Channels Analysis 
        11.2.1 Active Pharmaceutical Ingredients (API) Sales Channels 
        11.2.2 Active Pharmaceutical Ingredients (API) Distributors 
    11.3 Active Pharmaceutical Ingredients (API) Customers 
 
12 Opportunities   & Challenges, Threat and Affecting Factors  
    12.1 Market Opportunities 
    12.2 Market Challenges 
    12.3 Porter's Five Forces Analysis 
 
13 Key Findings  
 
14 Appendix  
    14.1 Research Methodology 
        14.1.1 Methodology/Research Approach 
            14.1.1.1 Research Programs/Design 
            14.1.1.2 Market Size Estimation 
            14.1.1.3 Market Breakdown and Data Triangulation 
        14.1.2 Data Source 
            14.1.2.1 Secondary Sources 
            14.1.2.2 Primary Sources 
    14.2 Author Details 
    14.3 Disclaimer 
List of Tables:
TABLE. 1  Table AbbVie Company Details
TABLE. 2  Table Active Pharmaceutical Ingredients (API) Customers List
TABLE. 3  Table Active Pharmaceutical Ingredients (API) Distributors List
TABLE. 4  Table Active Pharmaceutical Ingredients (API) Ex-factory Price by Type 2014-2019 (USD/MT)
TABLE. 5  Table Active Pharmaceutical Ingredients (API) Key Market Segments
TABLE. 6  Table Active Pharmaceutical Ingredients (API) Price by Manufacturers 2014-2019 (USD/MT)
TABLE. 7  Table Active Pharmaceutical Ingredients (API) Revenue Share by Manufacturers (2014-2019)
TABLE. 8  Table Active Pharmaceutical Ingredients (API) Revenue by Manufacturers (2014-2019) (Million USD)
TABLE. 9  Table Asia Pacific Active Pharmaceutical Ingredients (API) Consumption Forecast by Regions 2019-2025 (K MT)
TABLE. 10  Table Asia Pacific Active Pharmaceutical Ingredients (API) Consumption Market Share by Countries (2014-2019)
TABLE. 11  Table Asia Pacific Active Pharmaceutical Ingredients (API) Consumption by Application (2014-2019) (K MT)
TABLE. 12  Table Asia Pacific Active Pharmaceutical Ingredients (API) Consumption by Regions (2014-2019) (K MT)
TABLE. 13  Table Asia Pacific Active Pharmaceutical Ingredients (API) Consumption by Type (2014-2019) (K MT)
TABLE. 14  Table Aspen Active Pharmaceutical Ingredients (API) Production (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
TABLE. 15  Table Aspen Active Pharmaceutical Ingredients (API) Production Growth Rate (2014-2019)
TABLE. 16  Table Aspen Active Pharmaceutical Ingredients (API) Production Market Share in Global Market
TABLE. 17  Table Aspen Company Details
TABLE. 18  Table Aspen Description and Business Overview
TABLE. 19  Table Aspen Recent Development
TABLE. 20  Table Aurobindo Pharma Active Pharmaceutical Ingredients (API) Production (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
TABLE. 21  Table Aurobindo Pharma Active Pharmaceutical Ingredients (API) Production Growth Rate (2014-2019)
TABLE. 22  Table Aurobindo Pharma Active Pharmaceutical Ingredients (API) Production Market Share in Global Market
TABLE. 23  Table Aurobindo Pharma Company Details
TABLE. 24  Table Aurobindo Pharma Description and Business Overview
TABLE. 25  Table Aurobindo Pharma Recent Development
TABLE. 26  Table BASF Active Pharmaceutical Ingredients (API) Production (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
TABLE. 27  Table BASF Active Pharmaceutical Ingredients (API) Production Growth Rate (2014-2019)
TABLE. 28  Table BASF Active Pharmaceutical Ingredients (API) Production Market Share in Global Market
TABLE. 29  Table BASF Company Details
TABLE. 30  Table BASF Description and Business Overview
TABLE. 31  Table BASF Recent Development
TABLE. 32  Table Bayer Company Details
TABLE. 33  Table Central & South America Active Pharmaceutical Ingredients (API) Consumption Forecast by Regions 2019-2025 (K MT)
TABLE. 34  Table Central & South America Active Pharmaceutical Ingredients (API) Consumption by Application (2014-2019) (K MT)
TABLE. 35  Table Central & South America Active Pharmaceutical Ingredients (API) Consumption by Countries (2014-2019) (K MT)
TABLE. 36  Table Central & South America Active Pharmaceutical Ingredients (API) Consumption by Type (2014-2019) (K MT)
TABLE. 37  Table China Active Pharmaceutical Ingredients (API) Import & Export (K MT)
TABLE. 38  Table China Active Pharmaceutical Ingredients (API) Production and Value 2014-2019 (K MT) & (Million USD)
TABLE. 39  Table China Active Pharmaceutical Ingredients (API) Production and Value Forecast 2019-2025 (K MT) & (Million US$)
TABLE. 40  Table DSM Active Pharmaceutical Ingredients (API) Production (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
TABLE. 41  Table DSM Active Pharmaceutical Ingredients (API) Production Growth Rate (2014-2019)
TABLE. 42  Table DSM Active Pharmaceutical Ingredients (API) Production Market Share in Global Market
TABLE. 43  Table DSM Company Details
TABLE. 44  Table DSM Description and Business Overview
TABLE. 45  Table DSM Recent Development
TABLE. 46  Table Date of Key Manufacturers Enter into Active Pharmaceutical Ingredients (API) Market
TABLE. 47  Table Dr. Reddy’s Laboratories Company Details
TABLE. 48  Table Europe Active Pharmaceutical Ingredients (API) Consumption Forecast by Regions 2019-2025 (K MT)
TABLE. 49  Table Europe Active Pharmaceutical Ingredients (API) Consumption by Application (2014-2019) (K MT)
TABLE. 50  Table Europe Active Pharmaceutical Ingredients (API) Consumption by Countries (2014-2019) (K MT)
TABLE. 51  Table Europe Active Pharmaceutical Ingredients (API) Consumption by Type (2014-2019) (K MT)
TABLE. 52  Table Europe Active Pharmaceutical Ingredients (API) Import & Export (K MT)
TABLE. 53  Table Europe Active Pharmaceutical Ingredients (API) Production and Value 2014-2019 (K MT) & (Million USD)
TABLE. 54  Table Europe Active Pharmaceutical Ingredients (API) Production and Value Forecast 2019-2025 (K MT) & (Million US$)
TABLE. 55  Table Global Active Pharmaceutical Ingredients (API) Capacity Market Share by Manufacturers (2014-2019)
TABLE. 56  Table Global Active Pharmaceutical Ingredients (API) Capacity by Manufacturers (2014-2019) (K MT)
TABLE. 57  Table Global Active Pharmaceutical Ingredients (API) Capacity, Production Forecast 2019-2025 (K MT)
TABLE. 58  Table Global Active Pharmaceutical Ingredients (API) Consumption Forecast by Application 2019-2025 (K MT)
TABLE. 59  Table Global Active Pharmaceutical Ingredients (API) Consumption Forecast by Regions 2019-2025 (K MT)
TABLE. 60  Table Global Active Pharmaceutical Ingredients (API) Consumption Market Share by Regions 2014-2019
TABLE. 61  Table Global Active Pharmaceutical Ingredients (API) Consumption Share by Application (2014-2019)
TABLE. 62  Table Global Active Pharmaceutical Ingredients (API) Consumption by Application (2014-2019) (K MT)
TABLE. 63  Table Global Active Pharmaceutical Ingredients (API) Consumption by Regions 2014-2019 (K MT)
TABLE. 64  Table Global Active Pharmaceutical Ingredients (API) Growth Rate of Key Regions 2019-2025 (Million USD)
TABLE. 65  Table Global Active Pharmaceutical Ingredients (API) Manufacturers Market Concentration Ratio (CR5 and HHI)
TABLE. 66  Table Global Active Pharmaceutical Ingredients (API) Market Share by Application 2019-2025 (K MT)
TABLE. 67  Table Global Active Pharmaceutical Ingredients (API) Market Share for of Regions 2019-2025 (K MT)
TABLE. 68  Table Global Active Pharmaceutical Ingredients (API) Market Size Growth Rate by Type 2019-2025 (K MT) & (Million US$)
TABLE. 69  Table Global Active Pharmaceutical Ingredients (API) Market Size of Key Regions (Million USD) & (K MT)
TABLE. 70  Table Global Active Pharmaceutical Ingredients (API) Production Forecast by Regions 2019-2025 (K MT)
TABLE. 71  Table Global Active Pharmaceutical Ingredients (API) Production Forecast by Type 2019-2025 (K MT)
TABLE. 72  Table Global Active Pharmaceutical Ingredients (API) Production Market Share by Regions 2014-2019
TABLE. 73  Table Global Active Pharmaceutical Ingredients (API) Production Share by Manufacturers (2014-2019)
TABLE. 74  Table Global Active Pharmaceutical Ingredients (API) Production Share by Type (2014-2019)
TABLE. 75  Table Global Active Pharmaceutical Ingredients (API) Production Value Forecast by Regions 2019-2025 (Million US$)
TABLE. 76  Table Global Active Pharmaceutical Ingredients (API) Production Value Forecast by Type 2019-2025 (Million US$)
TABLE. 77  Table Global Active Pharmaceutical Ingredients (API) Production Value Market Share by Regions 2014-2019
TABLE. 78  Table Global Active Pharmaceutical Ingredients (API) Production Value Share by Type (2014-2019)
TABLE. 79  Table Global Active Pharmaceutical Ingredients (API) Production Value by Regions 2014-2019 (Million USD)
TABLE. 80  Table Global Active Pharmaceutical Ingredients (API) Production Value by Type (2014-2019) (Million US$)
TABLE. 81  Table Global Active Pharmaceutical Ingredients (API) Production by Manufacturers (2014-2019) (K MT)
TABLE. 82  Table Global Active Pharmaceutical Ingredients (API) Production by Regions 2014-2019 (K MT)
TABLE. 83  Table Global Active Pharmaceutical Ingredients (API) Production by Type (2014-2019) (K MT)
TABLE. 84  Table Global Active Pharmaceutical Ingredients (API) Revenue Forecast 2019-2025 (Million US$)
TABLE. 85  Table Global Biotech APIs Production and Production Value (2014-2019) (K MT) & (Million US$)
TABLE. 86  Table Global Synthetic APIs Production and Production Value (2014-2019) (K MT) & (Million US$)
TABLE. 87  Table Harbin Pharmaceutical Company Details
TABLE. 88  Table Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Production (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
TABLE. 89  Table Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Production Growth Rate (2014-2019)
TABLE. 90  Table Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Production Market Share in Global Market
TABLE. 91  Table Hisun Pharmaceutical Company Details
TABLE. 92  Table Hisun Pharmaceutical Description and Business Overview
TABLE. 93  Table Hisun Pharmaceutical Recent Development
TABLE. 94  Table Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Production (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
TABLE. 95  Table Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Production Growth Rate (2014-2019)
TABLE. 96  Table Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Production Market Share in Global Market
TABLE. 97  Table Huahai Pharmaceutical Company Details
TABLE. 98  Table Huahai Pharmaceutical Description and Business Overview
TABLE. 99  Table Huahai Pharmaceutical Recent Development
TABLE. 100  Table Japan Active Pharmaceutical Ingredients (API) Import & Export (K MT)
TABLE. 101  Table Japan Active Pharmaceutical Ingredients (API) Production and Value 2014-2019 (K MT) & (Million USD)
TABLE. 102  Table Japan Active Pharmaceutical Ingredients (API) Production and Value Forecast 2019-2025 (K MT) & (Million US$)
TABLE. 103  Table Key Data Information from Primary Sources
TABLE. 104  Table Key Data Information from Secondary Sources
TABLE. 105  Table Key Manufacturers Active Pharmaceutical Ingredients (API) Area Served
TABLE. 106  Table Key Manufacturers Active Pharmaceutical Ingredients (API) Capacity (K MT)
TABLE. 107  Table Key Manufacturers Active Pharmaceutical Ingredients (API) Plants/Factories Distribution
TABLE. 108  Table Key Manufacturers Active Pharmaceutical Ingredients (API) Product Type
TABLE. 109  Table LKPC Company Details
TABLE. 110  Table Major Manufacturers Active Pharmaceutical Ingredients (API) Covered in This Report
TABLE. 111  Table Major Manufacturers of Biotech APIs
TABLE. 112  Table Major Manufacturers of Synthetic APIs
TABLE. 113  Table Market Top Trends
TABLE. 114  Table Mergers & Acquisitions, Expansion Plans
TABLE. 115  Table Middle East and Africa Active Pharmaceutical Ingredients (API) Consumption Forecast by Regions 2019-2025 (K MT)
TABLE. 116  Table Middle East and Africa Active Pharmaceutical Ingredients (API) Consumption by Application (2014-2019) (K MT)
TABLE. 117  Table Middle East and Africa Active Pharmaceutical Ingredients (API) Consumption by Type (2014-2019) (K MT)
TABLE. 118  Table Mylan Active Pharmaceutical Ingredients (API) Production (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
TABLE. 119  Table Mylan Active Pharmaceutical Ingredients (API) Production Growth Rate (2014-2019)
TABLE. 120  Table Mylan Active Pharmaceutical Ingredients (API) Production Market Share in Global Market
TABLE. 121  Table Mylan Company Details
TABLE. 122  Table Mylan Description and Business Overview
TABLE. 123  Table Mylan Recent Development
TABLE. 124  Table NCPC Company Details
TABLE. 125  Table North America Active Pharmaceutical Ingredients (API) Consumption Forecast by Regions 2019-2025 (K MT)
TABLE. 126  Table North America Active Pharmaceutical Ingredients (API) Consumption by Application (2014-2019) (K MT)
TABLE. 127  Table North America Active Pharmaceutical Ingredients (API) Consumption by Countries (2014-2019) (K MT)
TABLE. 128  Table North America Active Pharmaceutical Ingredients (API) Consumption by Type (2014-2019) (K MT)
TABLE. 129  Table North America Active Pharmaceutical Ingredients (API) Import & Export (K MT)
TABLE. 130  Table North America Active Pharmaceutical Ingredients (API) Production and Value 2014-2019 (K MT) & (Million USD)
TABLE. 131  Table North America Active Pharmaceutical Ingredients (API) Production and Value Forecast 2019-2025 (K MT) & (Million US$)
TABLE. 132  Table Northeast Pharm Company Details
TABLE. 133  Table Novartis Active Pharmaceutical Ingredients (API) Production (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
TABLE. 134  Table Novartis Active Pharmaceutical Ingredients (API) Production Growth Rate (2014-2019)
TABLE. 135  Table Novartis Active Pharmaceutical Ingredients (API) Production Market Share in Global Market
TABLE. 136  Table Novartis Company Details
TABLE. 137  Table Novartis Description and Business Overview
TABLE. 138  Table Novartis Recent Development
TABLE. 139  Table Pfizer Active Pharmaceutical Ingredients (API) Production (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
TABLE. 140  Table Pfizer Active Pharmaceutical Ingredients (API) Production Growth Rate (2014-2019)
TABLE. 141  Table Pfizer Active Pharmaceutical Ingredients (API) Production Market Share in Global Market
TABLE. 142  Table Pfizer Company Details
TABLE. 143  Table Pfizer Description and Business Overview
TABLE. 144  Table Pfizer Recent Development
TABLE. 145  Table Porter's Five Forces Analysis
TABLE. 146  Table Research Programs/Design for This Report
TABLE. 147  Table Shandong Xinhua Pharmaceutical Company Details
TABLE. 148  Table Sun Pharmaceutical Industries Company Details
TABLE. 149  Table Teva Active Pharmaceutical Ingredients (API) Production (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
TABLE. 150  Table Teva Active Pharmaceutical Ingredients (API) Production Growth Rate (2014-2019)
TABLE. 151  Table Teva Active Pharmaceutical Ingredients (API) Production Market Share in Global Market
TABLE. 152  Table Teva Company Details
TABLE. 153  Table Teva Description and Business Overview
TABLE. 154  Table Teva Recent Development
TABLE. 155  Table Zhejiang Medicine Company Details
TABLE. 156  Table Zhejiang NHU Company Details
List of Figures:
FIG. 1  Table AbbVie Company Details
FIG. 2  Table Active Pharmaceutical Ingredients (API) Customers List
FIG. 3  Table Active Pharmaceutical Ingredients (API) Distributors List
FIG. 4  Table Active Pharmaceutical Ingredients (API) Ex-factory Price by Type 2014-2019 (USD/MT)
FIG. 5  Table Active Pharmaceutical Ingredients (API) Key Market Segments
FIG. 6  Table Active Pharmaceutical Ingredients (API) Price by Manufacturers 2014-2019 (USD/MT)
FIG. 7  Table Active Pharmaceutical Ingredients (API) Revenue Share by Manufacturers (2014-2019)
FIG. 8  Table Active Pharmaceutical Ingredients (API) Revenue by Manufacturers (2014-2019) (Million USD)
FIG. 9  Table Asia Pacific Active Pharmaceutical Ingredients (API) Consumption Forecast by Regions 2019-2025 (K MT)
FIG. 10  Table Asia Pacific Active Pharmaceutical Ingredients (API) Consumption Market Share by Countries (2014-2019)
FIG. 11  Table Asia Pacific Active Pharmaceutical Ingredients (API) Consumption by Application (2014-2019) (K MT)
FIG. 12  Table Asia Pacific Active Pharmaceutical Ingredients (API) Consumption by Regions (2014-2019) (K MT)
FIG. 13  Table Asia Pacific Active Pharmaceutical Ingredients (API) Consumption by Type (2014-2019) (K MT)
FIG. 14  Table Aspen Active Pharmaceutical Ingredients (API) Production (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
FIG. 15  Table Aspen Active Pharmaceutical Ingredients (API) Production Growth Rate (2014-2019)
FIG. 16  Table Aspen Active Pharmaceutical Ingredients (API) Production Market Share in Global Market
FIG. 17  Table Aspen Company Details
FIG. 18  Table Aspen Description and Business Overview
FIG. 19  Table Aspen Recent Development
FIG. 20  Table Aurobindo Pharma Active Pharmaceutical Ingredients (API) Production (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
FIG. 21  Table Aurobindo Pharma Active Pharmaceutical Ingredients (API) Production Growth Rate (2014-2019)
FIG. 22  Table Aurobindo Pharma Active Pharmaceutical Ingredients (API) Production Market Share in Global Market
FIG. 23  Table Aurobindo Pharma Company Details
FIG. 24  Table Aurobindo Pharma Description and Business Overview
FIG. 25  Table Aurobindo Pharma Recent Development
FIG. 26  Table BASF Active Pharmaceutical Ingredients (API) Production (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
FIG. 27  Table BASF Active Pharmaceutical Ingredients (API) Production Growth Rate (2014-2019)
FIG. 28  Table BASF Active Pharmaceutical Ingredients (API) Production Market Share in Global Market
FIG. 29  Table BASF Company Details
FIG. 30  Table BASF Description and Business Overview
FIG. 31  Table BASF Recent Development
FIG. 32  Table Bayer Company Details
FIG. 33  Table Central & South America Active Pharmaceutical Ingredients (API) Consumption Forecast by Regions 2019-2025 (K MT)
FIG. 34  Table Central & South America Active Pharmaceutical Ingredients (API) Consumption by Application (2014-2019) (K MT)
FIG. 35  Table Central & South America Active Pharmaceutical Ingredients (API) Consumption by Countries (2014-2019) (K MT)
FIG. 36  Table Central & South America Active Pharmaceutical Ingredients (API) Consumption by Type (2014-2019) (K MT)
FIG. 37  Table China Active Pharmaceutical Ingredients (API) Import & Export (K MT)
FIG. 38  Table China Active Pharmaceutical Ingredients (API) Production and Value 2014-2019 (K MT) & (Million USD)
FIG. 39  Table China Active Pharmaceutical Ingredients (API) Production and Value Forecast 2019-2025 (K MT) & (Million US$)
FIG. 40  Table DSM Active Pharmaceutical Ingredients (API) Production (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
FIG. 41  Table DSM Active Pharmaceutical Ingredients (API) Production Growth Rate (2014-2019)
FIG. 42  Table DSM Active Pharmaceutical Ingredients (API) Production Market Share in Global Market
FIG. 43  Table DSM Company Details
FIG. 44  Table DSM Description and Business Overview
FIG. 45  Table DSM Recent Development
FIG. 46  Table Date of Key Manufacturers Enter into Active Pharmaceutical Ingredients (API) Market
FIG. 47  Table Dr. Reddy’s Laboratories Company Details
FIG. 48  Table Europe Active Pharmaceutical Ingredients (API) Consumption Forecast by Regions 2019-2025 (K MT)
FIG. 49  Table Europe Active Pharmaceutical Ingredients (API) Consumption by Application (2014-2019) (K MT)
FIG. 50  Table Europe Active Pharmaceutical Ingredients (API) Consumption by Countries (2014-2019) (K MT)
FIG. 51  Table Europe Active Pharmaceutical Ingredients (API) Consumption by Type (2014-2019) (K MT)
FIG. 52  Table Europe Active Pharmaceutical Ingredients (API) Import & Export (K MT)
FIG. 53  Table Europe Active Pharmaceutical Ingredients (API) Production and Value 2014-2019 (K MT) & (Million USD)
FIG. 54  Table Europe Active Pharmaceutical Ingredients (API) Production and Value Forecast 2019-2025 (K MT) & (Million US$)
FIG. 55  Table Global Active Pharmaceutical Ingredients (API) Capacity Market Share by Manufacturers (2014-2019)
FIG. 56  Table Global Active Pharmaceutical Ingredients (API) Capacity by Manufacturers (2014-2019) (K MT)
FIG. 57  Table Global Active Pharmaceutical Ingredients (API) Capacity, Production Forecast 2019-2025 (K MT)
FIG. 58  Table Global Active Pharmaceutical Ingredients (API) Consumption Forecast by Application 2019-2025 (K MT)
FIG. 59  Table Global Active Pharmaceutical Ingredients (API) Consumption Forecast by Regions 2019-2025 (K MT)
FIG. 60  Table Global Active Pharmaceutical Ingredients (API) Consumption Market Share by Regions 2014-2019
FIG. 61  Table Global Active Pharmaceutical Ingredients (API) Consumption Share by Application (2014-2019)
FIG. 62  Table Global Active Pharmaceutical Ingredients (API) Consumption by Application (2014-2019) (K MT)
FIG. 63  Table Global Active Pharmaceutical Ingredients (API) Consumption by Regions 2014-2019 (K MT)
FIG. 64  Table Global Active Pharmaceutical Ingredients (API) Growth Rate of Key Regions 2019-2025 (Million USD)
FIG. 65  Table Global Active Pharmaceutical Ingredients (API) Manufacturers Market Concentration Ratio (CR5 and HHI)
FIG. 66  Table Global Active Pharmaceutical Ingredients (API) Market Share by Application 2019-2025 (K MT)
FIG. 67  Table Global Active Pharmaceutical Ingredients (API) Market Share for of Regions 2019-2025 (K MT)
FIG. 68  Table Global Active Pharmaceutical Ingredients (API) Market Size Growth Rate by Type 2019-2025 (K MT) & (Million US$)
FIG. 69  Table Global Active Pharmaceutical Ingredients (API) Market Size of Key Regions (Million USD) & (K MT)
FIG. 70  Table Global Active Pharmaceutical Ingredients (API) Production Forecast by Regions 2019-2025 (K MT)
FIG. 71  Table Global Active Pharmaceutical Ingredients (API) Production Forecast by Type 2019-2025 (K MT)
FIG. 72  Table Global Active Pharmaceutical Ingredients (API) Production Market Share by Regions 2014-2019
FIG. 73  Table Global Active Pharmaceutical Ingredients (API) Production Share by Manufacturers (2014-2019)
FIG. 74  Table Global Active Pharmaceutical Ingredients (API) Production Share by Type (2014-2019)
FIG. 75  Table Global Active Pharmaceutical Ingredients (API) Production Value Forecast by Regions 2019-2025 (Million US$)
FIG. 76  Table Global Active Pharmaceutical Ingredients (API) Production Value Forecast by Type 2019-2025 (Million US$)
FIG. 77  Table Global Active Pharmaceutical Ingredients (API) Production Value Market Share by Regions 2014-2019
FIG. 78  Table Global Active Pharmaceutical Ingredients (API) Production Value Share by Type (2014-2019)
FIG. 79  Table Global Active Pharmaceutical Ingredients (API) Production Value by Regions 2014-2019 (Million USD)
FIG. 80  Table Global Active Pharmaceutical Ingredients (API) Production Value by Type (2014-2019) (Million US$)
FIG. 81  Table Global Active Pharmaceutical Ingredients (API) Production by Manufacturers (2014-2019) (K MT)
FIG. 82  Table Global Active Pharmaceutical Ingredients (API) Production by Regions 2014-2019 (K MT)
FIG. 83  Table Global Active Pharmaceutical Ingredients (API) Production by Type (2014-2019) (K MT)
FIG. 84  Table Global Active Pharmaceutical Ingredients (API) Revenue Forecast 2019-2025 (Million US$)
FIG. 85  Table Global Biotech APIs Production and Production Value (2014-2019) (K MT) & (Million US$)
FIG. 86  Table Global Synthetic APIs Production and Production Value (2014-2019) (K MT) & (Million US$)
FIG. 87  Table Harbin Pharmaceutical Company Details
FIG. 88  Table Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Production (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
FIG. 89  Table Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Production Growth Rate (2014-2019)
FIG. 90  Table Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Production Market Share in Global Market
FIG. 91  Table Hisun Pharmaceutical Company Details
FIG. 92  Table Hisun Pharmaceutical Description and Business Overview
FIG. 93  Table Hisun Pharmaceutical Recent Development
FIG. 94  Table Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Production (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
FIG. 95  Table Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Production Growth Rate (2014-2019)
FIG. 96  Table Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Production Market Share in Global Market
FIG. 97  Table Huahai Pharmaceutical Company Details
FIG. 98  Table Huahai Pharmaceutical Description and Business Overview
FIG. 99  Table Huahai Pharmaceutical Recent Development
FIG. 100  Table Japan Active Pharmaceutical Ingredients (API) Import & Export (K MT)
FIG. 101  Table Japan Active Pharmaceutical Ingredients (API) Production and Value 2014-2019 (K MT) & (Million USD)
FIG. 102  Table Japan Active Pharmaceutical Ingredients (API) Production and Value Forecast 2019-2025 (K MT) & (Million US$)
FIG. 103  Table Key Data Information from Primary Sources
FIG. 104  Table Key Data Information from Secondary Sources
FIG. 105  Table Key Manufacturers Active Pharmaceutical Ingredients (API) Area Served
FIG. 106  Table Key Manufacturers Active Pharmaceutical Ingredients (API) Capacity (K MT)
FIG. 107  Table Key Manufacturers Active Pharmaceutical Ingredients (API) Plants/Factories Distribution
FIG. 108  Table Key Manufacturers Active Pharmaceutical Ingredients (API) Product Type
FIG. 109  Table LKPC Company Details
FIG. 110  Table Major Manufacturers Active Pharmaceutical Ingredients (API) Covered in This Report
FIG. 111  Table Major Manufacturers of Biotech APIs
FIG. 112  Table Major Manufacturers of Synthetic APIs
FIG. 113  Table Market Top Trends
FIG. 114  Table Mergers & Acquisitions, Expansion Plans
FIG. 115  Table Middle East and Africa Active Pharmaceutical Ingredients (API) Consumption Forecast by Regions 2019-2025 (K MT)
FIG. 116  Table Middle East and Africa Active Pharmaceutical Ingredients (API) Consumption by Application (2014-2019) (K MT)
FIG. 117  Table Middle East and Africa Active Pharmaceutical Ingredients (API) Consumption by Type (2014-2019) (K MT)
FIG. 118  Table Mylan Active Pharmaceutical Ingredients (API) Production (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
FIG. 119  Table Mylan Active Pharmaceutical Ingredients (API) Production Growth Rate (2014-2019)
FIG. 120  Table Mylan Active Pharmaceutical Ingredients (API) Production Market Share in Global Market
FIG. 121  Table Mylan Company Details
FIG. 122  Table Mylan Description and Business Overview
FIG. 123  Table Mylan Recent Development
FIG. 124  Table NCPC Company Details
FIG. 125  Table North America Active Pharmaceutical Ingredients (API) Consumption Forecast by Regions 2019-2025 (K MT)
FIG. 126  Table North America Active Pharmaceutical Ingredients (API) Consumption by Application (2014-2019) (K MT)
FIG. 127  Table North America Active Pharmaceutical Ingredients (API) Consumption by Countries (2014-2019) (K MT)
FIG. 128  Table North America Active Pharmaceutical Ingredients (API) Consumption by Type (2014-2019) (K MT)
FIG. 129  Table North America Active Pharmaceutical Ingredients (API) Import & Export (K MT)
FIG. 130  Table North America Active Pharmaceutical Ingredients (API) Production and Value 2014-2019 (K MT) & (Million USD)
FIG. 131  Table North America Active Pharmaceutical Ingredients (API) Production and Value Forecast 2019-2025 (K MT) & (Million US$)
FIG. 132  Table Northeast Pharm Company Details
FIG. 133  Table Novartis Active Pharmaceutical Ingredients (API) Production (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
FIG. 134  Table Novartis Active Pharmaceutical Ingredients (API) Production Growth Rate (2014-2019)
FIG. 135  Table Novartis Active Pharmaceutical Ingredients (API) Production Market Share in Global Market
FIG. 136  Table Novartis Company Details
FIG. 137  Table Novartis Description and Business Overview
FIG. 138  Table Novartis Recent Development
FIG. 139  Table Pfizer Active Pharmaceutical Ingredients (API) Production (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
FIG. 140  Table Pfizer Active Pharmaceutical Ingredients (API) Production Growth Rate (2014-2019)
FIG. 141  Table Pfizer Active Pharmaceutical Ingredients (API) Production Market Share in Global Market
FIG. 142  Table Pfizer Company Details
FIG. 143  Table Pfizer Description and Business Overview
FIG. 144  Table Pfizer Recent Development
FIG. 145  Table Porter's Five Forces Analysis
FIG. 146  Table Research Programs/Design for This Report
FIG. 147  Table Shandong Xinhua Pharmaceutical Company Details
FIG. 148  Table Sun Pharmaceutical Industries Company Details
FIG. 149  Table Teva Active Pharmaceutical Ingredients (API) Production (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
FIG. 150  Table Teva Active Pharmaceutical Ingredients (API) Production Growth Rate (2014-2019)
FIG. 151  Table Teva Active Pharmaceutical Ingredients (API) Production Market Share in Global Market
FIG. 152  Table Teva Company Details
FIG. 153  Table Teva Description and Business Overview
FIG. 154  Table Teva Recent Development
FIG. 155  Table Zhejiang Medicine Company Details
FIG. 156  Table Zhejiang NHU Company Details

Reasons to Buy this Report



Fastest report delivery

Fastest report delivery

We have the fastest report delivery service with excellent after-sales support

 

In-depth analysis

In-depth analysis

We provide a comprehensive and in-depth analysis in every report that we sell

 

Large database

Large database

We own large database which will help our clients to get customized and syndicated research reports

 

Accurate data

Accurate data

To offer you accurate data, our seasoned analysts will be available to assist you

 


 

Ask a Question

Get in touch with us to find answers to all your business-related queries for fast results.

 

NOTE - The analysis, thoughts, views, facts, and opinions expressed in this report are of the respective research analysts. QYR Consulting does not necessarily endorse it or it is also not essentially formal views of QYR Consulting.



Active Pharmaceutical Ingredients (API) Market Report